The blood stem cell mutation, known as DNMT3A R882, leads to the growth of a large population of circulating blood cells that also contain this mutation.
New research finds that cells are much more precise in how they ingest substances than previously thought, opening the door to potential treatments for several diseases.
Cornell is creating unique opportunities for innovation in the rapidly evolving field of structural biology thanks to cutting-edge facilities and support for intercampus collaborations between Cornell's Ithaca campus and Weill Cornell Medicine.
Cole, M.D. ’94, is the assistant vice provost for information services and chief information officer at Weill Cornell Medicine. He will begin his new role Jan. 1, 2023.
The World Health Organization has selected the Division of Nutritional Sciences to lead systematic reviews and training supporting the development of WHO guidelines and research networks.
A $20 million gift from Andrew H. ’71 and Ann R. Tisch will foster engagement and collaboration between Cornell Tech and Weill Cornell Medicine, catalyzing new discoveries at the intersection of health and technology.
A Cornell multidisciplinary research center that studies chronic fatigue syndrome has received a five-year, $9.5 million grant from the National Institutes of Health – funding that will enable experts to continue work on the mysterious and debilitating condition.
From new approaches for tendon injury treatment to biomass-based construction materials, Cornell Engineering’s inaugural Sprout Awards are funding unique research projects with the potential to grow partnerships across Cornell.
Building on a legacy of groundbreaking advances in medicine and science, Weill Cornell Medicine today launched a $1.5 billion campaign that will harness emerging biomedical innovations to bring exemplary care to patients and create enduring change in medicine.